Last updated on August 2017

Effectiveness and Safety of Dysport (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity

Brief description of study

The purpose of this study is to assess the longitudinal attainment of subject centred and functional related goals (cumulated Goal Attainment Scale Total (GAS T) score) after abobotulinumtoxinA injection (including following repeated injection cycles where they occur) alongside spasticity management used in real life settings over a period of 18 months (and a maximum of six injection cycles).

Clinical Study Identifier: NCT03017729


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Frank Berenson

Clinical Integrative Research Central Atlanta
Atlanta, GA United States
  Connect »

Edward Dabrowski

William Beaumont Hospital Pediatric Research
Royal Oak, MI United States
  Connect »

Mark Gormley

Gillette Children's Specialty Healthcare
Saint Paul, MN United States
  Connect »

Jenny Wilson

Shriners Hospitals for Children
Portland, OR United States
  Connect »

Lewis Miller

Children's Hospital at Erlanger
Chattanooga, TN United States
  Connect »

Didem Inanoglu

Texas Children's
Plano, TX United States
  Connect »

Judy Gooch

Utah Neuro Rehabilitation
Murray, UT United States
  Connect »